Primary study · included by 1 review
Clinical factors associated with worse quality-of-life scores in United States thyroid cancer survivors
Goswami 2019 · Goswami Sneha, Peipert Benjamin J., Mongelli Michael N., et al. · Surgery · 2019
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · within 2 months after RIT | Prevalence 0.60 [0.28, 0.85] | 3 studies · 1502 participants | GRADE not reported |
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · between 2 and 6 months after RIT | Prevalence 0.37 [0.28, 0.47] | 4 studies · 392 participants | GRADE not reported |
1 including review in total.